---
document_datetime: 2026-02-06 10:01:30
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/kisunla-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: kisunla-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.5405677
conversion_datetime: 2026-02-09 22:03:42.512697
docling_version:
  docling-serve: 1.12.0
  docling-jobkit: 1.10.1
  docling: 2.72.0
  docling-core: 2.63.0
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Kisunla

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific informationafterauthorisation(archive).

| Applicationnumber      | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|------------------------|------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation type IA_IN / | E.4Changeinthenameand/or addressof | 05/02/2026                          |                                          | SmPC,                           |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                                       | the marketing Term name: E.4 authorisation holder, ASMF holder, storage site of the master and/or working cell bank, manufacturing site for an active substance, intermediate or finished product, primary and/or secondary packaging site, manufacturer responsible for batch release, site where quality control takes place, and/or supplier of a packaging component, medical device(part),starting material,reagent and/orexcipient(whenmentioned in the dossier-E.4.a)The change in the name and/or address concerns the marketing authorisationholder-Accepted   |            | Labelling and PL   | EMA/VR/0000315499   |
|---------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|--------------------|---------------------|
| Variation type IB / EMA/VR/0000309139 | B.II.b.3 Change in the manufacturing processofthefinishedproduct,including an intermediateusedinthemanufactureofthe finished product - B.11.b.3.z Other changes - Accepted                                                                                                                                                                                                                                                                                                                                                                                              | 24/11/2025 |                    |                     |
| Variation type IB / EMA/VR/0000316533 | C.I HUMANANDVETERINARYMEDICINAL PRODUCTS-C.I.zOther variation-Accepted C.I.z-to update thePackage Leaflet by removingthetear-offsection containing the patient card. In addition, the MAH took the opportunity to add the date of authorisation in section9of theSmPC.Finally,the MAH tooktheopportunitytomakesomeminor editorial corrections in the Spanish and                                                                                                                                                                                                        | 09/01/2026 | SmPC and PL        |                     |

<div style=\"page-break-after: always\"></div>

| Finnish annexes.   |
|--------------------|